Superworth

DexCom forward PE DXCM

Share price divided by analysts' consensus earnings for the next twelve months, since 2018.

Today, Nov 3, 2026
30.0×
8-year median
101×
Against its 8-year history
12th
percentile: 0 is its lowest day, 100 its highest
8-year range
22.8× to 412×
Peer median
17.7×

DexCom's forward PE is 30.0× as of Nov 3, 2026.

That is below its 8-year median of 101×, lower than on 88% of days in the last 8 years.

Over that time it ranged from 22.8× in May 2026 to 412× in Jan 2019.

The median for 9 medical device stocks of a similar size is 17.7×.

Forward PE over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far30.1×22.8×32.8×
202528.1×22.9×48.6×
202443.9×38.0×88.5×
202381.6×53.4×117×
2022115×81.2×160×
2021173×134×208×
2020159×102×199×
2019117×101×412×
2018326×298×412×

Against its peers

Companies in Medical - Devices nearest DexCom's size, closest first, today.

Where DexCom ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on DexCom

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.